IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Nabriva Therapeutics PLC

CUSIP: G63637113 | 56 institutional holders

Quarters

Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2022

IFP Advisors, Inc700
0.0% of portfolio›$1
StyleTurnoverLocationFiled
IFP Advisors, Inc
700$10.0%GrowthLowTampa, FL2022-11-08